KIOS Bipolar featured in The Rivard Report

KIOS Bipolar was recently featured in The Rivard Report. Read it here! The article interviews both Dr. Bowden and one of the patients in our 52-week clinical trial. Thank you to the Rivard Report for the coverage and to all our clinical trial participants for your cooperation in the study.

Share this post

© 2017 Biomedical Development Corporation. All rights reserved. Trademarks not belonging to BDC are the property of their respective companies. iPhone and iPad are registered trademarks of Apple Inc.

¹ Research reported in this publication was supported by the National Institute Of Mental Health of the National Institutes of Health under Award Number R42MH091997. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

² This technology was supported in part by an award from the Kentucky Cabinet for Economic Development, Office of Entrepreneurship, under the Grant Agreement KSTC-184-512-15-223 with the Kentucky Science and Technology Corporation